Understanding the neuroprotective effect of tranexamic acid: an exploratory analysis of the CRASH-3 randomised trial
Background: The CRASH-3 trial hypothesised that timely tranexamic acid (TXA) treatment might reduce deaths from intracranial bleeding after traumatic brain injury (TBI). To explore the mechanism of action of TXA in TBI, we examined the timing of its effect on death. Methods: The CRASH-3 trial random...
出版年: | Critical Care |
---|---|
第一著者: | |
フォーマット: | 論文 |
言語: | English |
出版事項: |
BioMed Central Ltd
2020
|
オンライン・アクセス: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85095781531&doi=10.1186%2fs13054-020-03243-4&partnerID=40&md5=15c5815a3482e941f90ef01220ef9d47 |